Vtd Regimen Comprising Velcade (V) Plus Thalidomide (T) And Added Dex (D) For Non-Responders To V+T Effects A 57% Pr Rate Among 56 Patients With Myeloma (M) Relapsing After Autologous Transplant.
BLOOD(2003)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要